{"id":"https://openalex.org/W2807639280","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","title":"First-line ribociclib (RIB) + letrozole (LET) in hormone receptor-positive (HR+), HER2-negative (HER2\u2013) advanced breast cancer (ABC): MONALEESA-2 biomarker analyses.","display_name":"First-line ribociclib (RIB) + letrozole (LET) in hormone receptor-positive (HR+), HER2-negative (HER2\u2013) advanced breast cancer (ABC): MONALEESA-2 biomarker analyses.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2807639280","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","mag":"2807639280"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.1022","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018617106","display_name":"Gabriel N. Hortob\u00e1gyi","orcid":"https://orcid.org/0000-0002-4873-4412","observed_orcids":["https://orcid.org/0000-0002-4873-4412","https://orcid.org/0000-0001-9030-4136"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel N. Hortobagyi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001211980","display_name":"Shani Paluch\u2013Shimon","orcid":"https://orcid.org/0000-0002-6677-2199","observed_orcids":["https://orcid.org/0000-0002-6677-2199"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Shani Paluch-Shimon","raw_affiliation_strings":["Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel;","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042433886","display_name":"Katar\u00edna Petr\u00e1kov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115043","display_name":"Masaryk Memorial Cancer Institute","ror":"https://ror.org/0270ceh40","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210115043"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Katarina Petrakova","raw_affiliation_strings":["Masaryk Memorial Cancer Institute, Brno, Czech Republic;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Masaryk Memorial Cancer Institute, Brno, Czech Republic;","institution_ids":["https://openalex.org/I4210115043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063597540","display_name":"Cristian Villanueva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cristian Villanueva","raw_affiliation_strings":["University Hospital of Besan\u00e7on, Jean-Minjoz Hospital, Besan\u00e7on, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Besan\u00e7on, Jean-Minjoz Hospital, Besan\u00e7on, France;","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005769474","display_name":"Arlene Chan","orcid":"https://orcid.org/0000-0003-2135-2286","observed_orcids":["https://orcid.org/0000-0003-2135-2286"]},"institutions":[{"id":"https://openalex.org/I205640436","display_name":"Curtin University","ror":"https://ror.org/02n415q13","country_code":"AU","type":"education","lineage":["https://openalex.org/I205640436"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Arlene Chan","raw_affiliation_strings":["Breast Cancer Research Centre - WA & Curtin University, Perth, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Research Centre - WA & Curtin University, Perth, Australia;","institution_ids":["https://openalex.org/I205640436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047277951","display_name":"Arnd Nusch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116299","display_name":"Strasbourg Oncologie Lib\u00e9rale","ror":"https://ror.org/01m10js32","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116299"]},{"id":"https://openalex.org/I4405268902","display_name":"European Society of Surgical Oncology","ror":"https://ror.org/02efszc08","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4405268902"]}],"countries":["BE","FR"],"is_corresponding":false,"raw_author_name":"Arnd Nusch","raw_affiliation_strings":["Onkologische Praxis Velbert, Velbert, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Onkologische Praxis Velbert, Velbert, Germany;","institution_ids":["https://openalex.org/I4210116299","https://openalex.org/I4405268902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052352446","display_name":"Yoon Sim Yap","orcid":"https://orcid.org/0000-0002-0347-5066","observed_orcids":["https://orcid.org/0000-0002-0347-5066"]},"institutions":[{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Yoon Sim Yap","raw_affiliation_strings":["National Cancer Centre Singapore, Singapore, Singapore;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Centre Singapore, Singapore, Singapore;","institution_ids":["https://openalex.org/I4210137145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111656761","display_name":"Lowell L. Hart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell Hart","raw_affiliation_strings":["Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Florida Cancer Specialists, Sarah Cannon Research Institute, Fort Myers, FL;","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076486609","display_name":"Anne M. Favret","orcid":"https://orcid.org/0000-0002-7917-5238","observed_orcids":["https://orcid.org/0000-0002-7917-5238"]},"institutions":[{"id":"https://openalex.org/I4210122908","display_name":"Virginia Cancer Specialists","ror":"https://ror.org/03tbabt10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122908"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Favret","raw_affiliation_strings":["Virginia Cancer Specialists, Arlington, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Cancer Specialists, Arlington, VA;","institution_ids":["https://openalex.org/I4210122908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034764832","display_name":"Norbert Walter Marschner","orcid":"https://orcid.org/0000-0002-6098-1301","observed_orcids":["https://orcid.org/0000-0002-6098-1301","https://orcid.org/0009-0001-7065-9690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norbert Marschner","raw_affiliation_strings":["Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048535376","display_name":"Gabe S. Sonke","orcid":"https://orcid.org/0000-0001-8088-9628","observed_orcids":["https://orcid.org/0000-0001-8088-9628"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I4210148394","display_name":"Borstkanker Onderzoek Groep","ror":"https://ror.org/04cr37s66","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210148394"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gabe S. Sonke","raw_affiliation_strings":["Netherlands Cancer Institute and BOOG Study Center, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute and BOOG Study Center, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I4210148394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073598050","display_name":"Hege Oma Ohnstad","orcid":"https://orcid.org/0000-0001-6932-0297","observed_orcids":["https://orcid.org/0000-0001-6932-0297"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Hege Oma Ohnstad","raw_affiliation_strings":["Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043946489","display_name":"Carlos L. Arteaga","orcid":"https://orcid.org/0000-0003-0870-9586","observed_orcids":["https://orcid.org/0000-0003-0870-9586"]},"institutions":[{"id":"https://openalex.org/I4390039370","display_name":"Harold C. Simmons Comprehensive Cancer Center","ror":"https://ror.org/03cbz4r60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Arteaga","raw_affiliation_strings":["Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101431610","display_name":"Fei Su","orcid":"https://orcid.org/0000-0003-4737-4651","observed_orcids":["https://orcid.org/0000-0003-4737-4651"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fei Su","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100774797","display_name":"Wei He","orcid":"https://orcid.org/0000-0001-9069-1447","observed_orcids":["https://orcid.org/0000-0001-9069-1447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei He","raw_affiliation_strings":["Novartis Institute for Biomedical Research, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institute for Biomedical Research, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103809369","display_name":"Michelle Kristine Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Kristine Miller","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007458418","display_name":"Salomon Marcello Stemmer","orcid":"https://orcid.org/0000-0002-8733-3929","observed_orcids":["https://orcid.org/0000-0002-8733-3929"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Salomon M. Stemmer","raw_affiliation_strings":["Davidoff Center, Rabin Medical Center, Tel-Aviv University, Tel-Aviv, Israel;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Davidoff Center, Rabin Medical Center, Tel-Aviv University, Tel-Aviv, Israel;","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"1022","last_page":"1022"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":1.0},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7689999938011169},{"id":"https://openalex.org/keywords/gene-expression-biomarkers","display_name":"gene expression biomarkers","score":0.8930000066757202},{"id":"https://openalex.org/keywords/esr1","display_name":"ESR1","score":0.847000002861023},{"id":"https://openalex.org/keywords/rb1","display_name":"RB1","score":0.9599999785423279},{"id":"https://openalex.org/keywords/e2f1","display_name":"E2F1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.6159999966621399},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8100000023841858},{"id":"https://openalex.org/keywords/nanostring","display_name":"NanoString","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7551419734954834},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7316629886627197},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.647683322429657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5958926677703857},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5906668901443481},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5377132892608643},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5253283977508545},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4851175546646118},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.478412002325058},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.46156564354896545},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4471104145050049},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4298357665538788},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3310582637786865},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3270310163497925},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.29962727427482605},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28159773349761963},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.1798350214958191},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12717825174331665},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0893036425113678}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.1022","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.1022","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2768081330","https://openalex.org/W2789830499","https://openalex.org/W2802776309","https://openalex.org/W2739985928","https://openalex.org/W2947234394","https://openalex.org/W2610327618","https://openalex.org/W4322775479","https://openalex.org/W2946946960","https://openalex.org/W2591774149","https://openalex.org/W3013767050"],"abstract_inverted_index":{"1022":[0],"Background:":[1],"In":[2],"MONALEESA-2,":[3],"first-line":[4],"RIB":[5,41,124,146,166,199],"+":[6,18,125,200,203],"LET":[7,19,126,201,204],"improved":[8,127],"investigator-assessed":[9],"progression-free":[10],"survival":[11],"(PFS;":[12],"primary":[13],"endpoint)":[14],"vs":[15,154,159],"placebo":[16],"(PBO)":[17],"in":[20,129,171,186,244,282],"postmenopausal":[21],"pts":[22,80],"with":[23],"HR+,":[24],"HER2\u2013":[25],"ABC.":[26],"Previous":[27],"MONALEESA-2":[28,47],"biomarker":[29],"analyses,":[30],"involving":[31],"immunohistochemistry,":[32],"gene":[33,48,59,75,150],"expression,":[34],"and":[35,78,86,99,118,157,185,207],"NGS":[36],"of":[37,145,173],"ctDNA,":[38],"showed":[39],"consistent":[40,148],"benefit.":[42,167],"Here,":[43],"we":[44],"present":[45],"additional":[46],"expression":[49,60,76,91,101,151,162],"data.":[50],"Methods:":[51],"Tumor":[52],"samples":[53],"(n/N,":[54],"391/668)":[55],"were":[56,81,112],"evaluated":[57],"for":[58,97,105],"using":[61,93],"the":[62,103],"NanoString":[63],"230-gene":[64],"nCounter\u00ae":[65],"GX":[66],"Human":[67],"Cancer":[68],"Reference":[69],"panel.":[70],"To":[71],"assess":[72],"correlations":[73],"between":[74],"level":[77,192],"PFS,":[79],"classified":[82],"into":[83],"low":[84],"(L)":[85],"high":[87],"(H)":[88],"messenger":[89],"RNA":[90],"subgroups":[92,132],"a":[94],"10%":[95],"cut-off":[96,104],"RB1":[98,221],"median":[100],"as":[102],"other":[106],"genes.":[107],"Cox":[108],"proportional":[109],"hazards":[110],"models":[111],"used":[113],"to":[114,175],"estimate":[115],"hazard":[116],"ratios":[117],"95%":[119,197],"confidence":[120],"intervals":[121],"(CI).":[122],"Results:":[123],"PFS":[128],"all":[130],"pt":[131],"(Table).":[133],"Kaplan\u2013Meier":[134],"curves":[135],"will":[136],"be":[137],"presented.":[138],"Clinical":[139],"trial":[140],"information:":[141],"NCT01958021.":[142],"Conclusions:":[143],"Benefit":[144],"was":[147],"across":[149],"subgroups;":[152],"H":[153,160,216,227,238,254,265,276,293,305,317,328],"L":[155,158,211,222,233,249,260,271,288,300,312,323],"ESR1":[156,210],"RTK":[161],"trended":[163],"towards":[164],"greater":[165],"Genes":[168],"implicated":[169],"preclinically":[170],"mechanisms":[172],"resistance":[174,247],"CDK4/6":[176,245],"inhibitors":[177],"require":[178],"further":[179],"investigation":[180],"based":[181],"on":[182],"metastatic/liquid":[183],"biopsies,":[184],"larger":[187],"clinical":[188],"datasets.":[189],"Gene(s)":[190],"Expression":[191],"Events,":[193],"n/N":[194],"Hazard":[195],"ratio;":[196],"CI":[198],"PBO":[202],"CDK":[205],"pathway":[206,299,311],"breast":[208],"cancer":[209],"51/101":[212],"62/95":[213],"0.74;":[214,331],"0.51\u20131.07":[215],"34/96":[217],"58/99":[218],"0.39;":[219],"0.25\u20130.60":[220],"11/21":[223],"14/19":[224],"0.52;":[225,241],"0.23\u20131.16":[226],"74/176":[228],"106/175":[229],"0.55;":[230,315],"0.41\u20130.74":[231],"E2F1":[232],"31/105":[234],"45/91":[235],"0.56;":[236,320],"0.35\u20130.89":[237],"54/92":[239],"75/103":[240],"0.37\u20130.75":[242],"Implicated":[243],"inhibitor":[246],"CDK2":[248],"40/103":[250],"49/93":[251],"0.64;":[252],"0.42\u20130.98":[253],"45/94":[255],"71/101":[256],"0.48;":[257],"0.33\u20130.71":[258],"CCNE1":[259],"32/97":[261],"51/99":[262],"0.53;":[263],"0.34\u20130.83":[264],"53/100":[266],"69/95":[267],"0.54;":[268,308],"0.38\u20130.78":[269],"FGFR1":[270],"32/93":[272],"59/103":[273],"0.45;":[274,296],"0.29\u20130.69":[275],"53/104":[277],"61/91":[278],"0.63;":[279],"0.43\u20130.91":[280],"Involved":[281],"alternative":[283],"pathways":[284],"Cell":[285],"cycle":[286],"control":[287],"32/99":[289],"47/97":[290],"0.66;":[291],"0.42\u20131.03":[292],"53/98":[294],"73/97":[295],"0.31\u20130.64":[297],"PI3K":[298],"37/98":[301],"54/98":[302],"0.57;":[303],"0.37\u20130.86":[304],"48/99":[306],"66/96":[307],"0.37\u20130.79":[309],"MAPK":[310],"42/99":[313],"61/97":[314],"0.37\u20130.81":[316],"43/98":[318],"59/97":[319],"0.37\u20130.83":[321],"RTKs":[322],"39/103":[324],"59/93":[325],"0.41;":[326],"0.27\u20130.61":[327],"46/94":[329],"61/101":[330],"0.50\u20131.08":[332]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-06-13T00:00:00"}